T Peter Bridge

Summary

Country: USA

Publications

  1. ncbi Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence
    T Peter Bridge
    Division of Treatment Research and Development, National Institute on Drug Abuse, Bethesda, MD 20892, USA
    Drug Alcohol Depend 70:S79-85. 2003

Collaborators

Detail Information

Publications1

  1. ncbi Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence
    T Peter Bridge
    Division of Treatment Research and Development, National Institute on Drug Abuse, Bethesda, MD 20892, USA
    Drug Alcohol Depend 70:S79-85. 2003
    ....